Funding for this research was provided by:
Medical Research Council (MC_UU_00011/1; MC_UU_00011/6; MC_UU_00011/7; MR/V033867/1)
Diabetes UK (17/0005700)
British Heart Foundation (AA/18/1/34219; CH/F/20/90003)
National Institute of Health (NF-0616-10102)
Article History
Received: 2 November 2022
Accepted: 13 March 2023
First Online: 3 April 2023
Declarations
:
: The data collection in UK Biobank was approved by the NHS National Research Ethics Service (ref 11/NW/0382). All data-sets used in this data obtained fully informed consent from participants.
: Not applicable.
: All authors have completed the ICMJE uniform disclosure form at ExternalRef removed. DAL has received support from Roche Diagnostics and Medtronic Ltd for biomarker research unrelated to this paper. MJG and LACM declare no support from any organisation for the submitted work; no financial relationships with any organisations that might have an interest in the submitted work in the previous three years; no other relationships or activities that could appear to have influenced the submitted work.